Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0P1XM
|
||||
| Former ID |
DNC004190
|
||||
| Drug Name |
L-736281
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [534156] | ||
| Formula |
C22H22F6N2O2
|
||||
| Canonical SMILES |
C1CC(C(N(C1)CC(=O)N)C2=CC=CC=C2)OCC3=CC(=CC(=C3)C(F)(F)<br />F)C(F)(F)F
|
||||
| InChI |
1S/C22H22F6N2O2/c23-21(24,25)16-9-14(10-17(11-16)22(26,27)28)13-32-18-7-4-8-30(12-19(29)31)20(18)15-5-2-1-3-6-15/h1-3,5-6,9-11,18,20H,4,7-8,12-13H2,(H2,29,31)/t18-,20-/m0/s1
|
||||
| InChIKey |
SUZSWSSXVHSRLT-ICSRJNTNSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Substance-P receptor | Target Info | Inhibitor | [534156] | |
| PANTHER Pathway | CCKR signaling map ST | ||||
| Reactome | G alpha (q) signalling events | ||||
| References | |||||